S100 calcium binding protein B as a biomarker of delirium duration in the intensive care unit - An exploratory analysis

International Journal of General Medicine

Volumn 6, Issue , 2013, Pages 855-861

  Khan, Babar A ^a,b,c   Farber, Marker O ^a   Campbell, Noll ^b,c,d,e   Perkins, Anthony ^b,c   Prasad, Nagendra K ^f   Hui, Sui L ^a,b,c   Miller, Douglas K ^a,b,c   Calvo Ayala, Enrique ^a   Buckley, John D ^a   Ionescu, Ruxandra ^a   Shekhar, Anantha ^a   Ely, E Wesley ^g,h   Boustani, Malaz A ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY CENTER FOR AGING RESEARCH   (United States)

^c REGENSTRIEF INSTITUTE   (United States)

^d WISHARD HEALTH SERVICES   (United States)

^e PURDUE UNIVERSITY   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h VA Tennessee Valley Geriatric Research Education and Clinical Center (GRECC)   (United States)

Author keywords

Astrocytes; Blood brain barrier; Coma; S100

Indexed keywords

BINDING PROTEIN; PROTEIN S100B;

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DELIRIUM; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; EXPLORATORY RESEARCH; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; UNITED STATES;

EID: 84889020999     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S51004     Document Type: Article

References (37)

1. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal A P, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113(12):941-948.
2. Khan BA, Guzman O, Campbell NL, et al. Comparison and agreement between the Richmond Agitation-Sedation Scale and the Riker Sedation-Agitation Scale in evaluating patients' eligibility for delirium assessment in the ICU. Chest. 2012;142(1):48-54.
3. Lin SM, Liu C Y, Wang CH, et al. The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med. 2004;32(11): 2254-2259.
4. Pisani MA, Kong SY, Kasl S V, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009;180(11): 1092-1097.
5. Khan BA, Zawahiri M, Campbell NL, Boustani MA. Biomarkers for delirium - a review. Journal of the American Geriatrics Society. Nov 2011;59 Suppl 2:S256-S261.
6. Pinto SS, Gottfried C, Mendez A, et al. Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology. FEBS letters. 2000;486(3):203-207.
7. Porter JT, McCarthy KD. Astrocytic neurotransmitter receptors in situ and in vivo. Prog Neurobiol. 1997;51(4):439-455.
8. Cerejeira J, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB. The neuroinflammatory hypothesis of delirium. Acta Neuropathol. 2010;119(6):737-754.
9. Prat A, Biernacki K, Wosik K, Antel J P. Glial cell influence on the human blood-brain barrier. Glia. 2001;36(2):145-155.
10. Koehler RC, Gebremedhin D, Harder DR. Role of astrocytes in cere-brovascular regulation. J Appl Physiol. 2006;100(1):307-317.
11. Han HS, Suk K. The function and integrity of the neurovascular unit rests upon the integration of the vascular and inflammatory cell systems. Curr Neurovasc Res. 2005;2(5):409-423.
12. Kanner AA, Marchi N, Fazio V, et al. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer. 2003;97(11):2806-2813.
13. Kapural M, Krizanac-Bengez L, Barnett G, et al. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res. 2002;940(1-2):102-104.
14. Marchi N, Rasmussen P, Kapural M, et al. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neurosci. 2003;21(3-4):109-121.
15. van Munster BC, Bisschop PH, Zwinderman AH, et al. Cortisol, interleukins and S100B in delirium in the elderly. Brain Cogn. 2010;74(1):18-23.
16. Pfster D, Siegemund M, Dell-Kuster S, et al. Cerebral perfusion in sepsis-associated delirium. Crit Care. 2008;12(3):R63.
17. Rasmussen LS, Christiansen M, Rasmussen H, Kristensen PA, Moller JT. Do blood concentrations of neurone specific enolase and S-100beta protein refect cognitive dysfunction after abdominal surgery?ISPOCD Group. Br J Anaesth. 2000;84(2):242-244.
18. van Munster BC, Korevaar JC, Korse CM, Bonfrer JM, Zwinderman AH, de Rooij SE. Serum S100B in elderly patients with and without delirium. Int J Geriatr Psychiatry. 2010;25(3):234-239.
19. van Munster BC, Korse CM, de Rooij SE, Bonfrer JM, Zwinderman AH, Korevaar JC. Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol. 2009;9:21.
20. Siami S, Annane D, Sharshar T. The encephalopathy in sepsis. Crti Care Clin. 2008;24(1):67-82, viii.
21. Shimaoka M, Park EJ. Advances in understanding sepsis. Eur J Anaesthesiol Suppl. 2008;42:146-153.
22. Ely E W, Siegel MD, Inouye SK. Delirium in the intensive care unit: an under-recognized syndrome of organ dysfunction. Semin Respir Crit Care Med. 2001;22(2):115-126.
23. Regenstrief Institute, IU Center for Aging Research. Pharmacological Management of Delirium (PMD). Available from: http://clinicaltrials. gov/show/NCT00842608. NLM identifier: NCT00842608. Accessed October 31, 2013.
24. Campbell NL, Khan BA, Farber M, et al. Improving delirium care in the intensive care unit: the design of a pragmatic study. Trials. 2011;12:139.
25. Ely E W, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21): 2703-2710.
26. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-1344.
27. Wiesmann M, Missler U, Gottmann D, Gehring S. Plasma S-100b protein concentration in healthy adults is age- and sex-independent. Clin Chem. 1998;44(5):1056-1058.
28. Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG. Assessing illness severity: does clinical judgment work? J Chronic Dis. 1986;39(6):439-452.
29. Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr. 2004;16(3):275-293.
30. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classifcation system. Crit Care Med. 1985;13(10): 818-829.
31. Routsi C, Stamataki E, Nanas S, et al. Increased levels of serum S100B protein in critically ill patients without brain injury. Shock. 2006;26(1):20-24.
32. Snyder-Ramos SA, Gruhlke T, Bauer H, et al. Cerebral and extracere-bral release of protein S100B in cardiac surgical patients. Anaesthesia. 2004;59(4):344-349.
33. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;48(6):1255-1258; discussion 1258-1260.
34. Scaccianoce S, Del Bianco P, Pannitteri G, Passarelli F. Relationship between stress and circulating levels of S100B protein. Brain Res. 2004;1004(1-2):208-211.
35. Nguyen DN, Spapen H, Su F, et al. Elevated serum levels of S-100beta protein and neuron-specifc enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med. 2006;34(7): 1967-1974.
36. Grandi C, Tomasi CD, Fernandes K, et al. Brain-derived neurotrophic factor and neuron-specific enolase, but not S100beta, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care. 2011;26(2):133-137.
37. Kyzas PA, Denaxa-Kyza D, Ioannidis J P. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. J Natl Cancer Inst. 2007;99(3):236-243.